Dr Sarah Heynemann

#Oncology #Ethics #Trials Med Onc/PhD candidate @SydHealthEthics Aim: conversations which promote human flourishing.Views my own. Retweets do not = endorsement.

[Dr Sarah Heynemann @CancerEthicsDoc]

⭐️ NEW PUBLICATION⭐️In 2024 @iaslc's JTO published a debate on the role of #equipoise in Ph3 RCTs of precision oncology therapeutics in #NSCLC. (See prior 🧵https://t.co/MiatTvtAeK) In a new letter we highlight key implications if equipoise is uncertain in a given RCT...

[Dr Sarah Heynemann @CancerEthicsDoc]

⭐️ New Paper⭐️ Equipoise + modern cancer RCTs, using thoracic oncology as an exemplar - whose uncertainty matters (most)? 💥 A debate💥

https://t.co/yIj3H0cTYp with @WendyLipworth McLachlan @JenAMPhilip @TommyJohn00 Kerridge @SydHealthEthics

In this paper, we outline- a 🧵

[Sharon Nahm @sharonnahm]

How do oncologists balance maintaining hope & truth-telling? When & how should they challenge unrealistic hope?
Less than 1 wk to go for this MOGA Medical Ethics Webinar. Participants can log CPD points for ethics & professional behaviour. Register today!
https://t.co/IXj33QoSjW

[Dr Sarah Heynemann @CancerEthicsDoc]

@cancer_K2A What a workmate! I mean how much ‘work’ can you get done with a colleague like this??

[Nicolas Hart @DrNicolasHart]

A standing ovation for #CHALLENGE trial at #ASCO25 - first in world to definitively show exercise reduces recurrence and improves survival:

“For every 16 people, exercise prevents 1 person from recurrent/new cancer”

“For every 14 people, exercise prevents 1 person from dying”

[Dr Sarah Heynemann @CancerEthicsDoc]

@TOGAANZ @EGFRResisters @KRASKickers @ros1cancer @ALKPositiveinc @ALKpositiveINT

[Dr Sarah Heynemann @CancerEthicsDoc]

⭐️ NEW PUBLICATION⭐️In 2024 @iaslc's JTO published a debate on the role of #equipoise in Ph3 RCTs of precision oncology therapeutics in #NSCLC. (See prior 🧵https://t.co/MiatTvtAeK) In a new letter we highlight key implications if equipoise is uncertain in a given RCT...

[Dr Sarah Heynemann @CancerEthicsDoc]

⭐️ New Paper⭐️ Equipoise + modern cancer RCTs, using thoracic oncology as an exemplar - whose uncertainty matters (most)? 💥 A debate💥

https://t.co/yIj3H0cTYp with @WendyLipworth McLachlan @JenAMPhilip @TommyJohn00 Kerridge @SydHealthEthics

In this paper, we outline- a 🧵

[Dr Sarah Heynemann @CancerEthicsDoc]

See full argument here: https://t.co/wa0IP5HbI2

with @WendyLipworth Sue-Anne McLachlan Jennifer Philip @TommyJohn00 Ian Kerridge @SydHealthEthics

[Dr Sarah Heynemann @CancerEthicsDoc]

@drcarolynee @PC4TG Congratulations Carolyn! What a great appointment!

[Dr Sarah Heynemann @CancerEthicsDoc]

@DrNicolasHart @Lisa_Beatty @COSAoncology Agree, great to see met survivorship on the agenda. And Dr Andrea Smith’s talk by far the most humbling & impactful

[The Daffodil Centre @DaffodilCentre]

📰IN THE MEDIA⬇️| A new best practice guide developed by @PathologyRCPA and @TOGAANZ offers valuable recommendations for lung cancer care. However, concerns remain about the potential impact of stigma on participation in the #NationalLungCancerScreeningProgram.

🔬A media content analysis led by #DaffodilCentre Postdoctoral Research Fellow Dr Shiho Rose and her team revealed that stigmatising language - such as blame-focused terms and moralising narratives - continues to be prevalent in media coverage.

🔍The media plays a critical role in challenging the stigma surrounding lung cancer and encouraging people to engage in the screening program.

🌐Read the full article via @MedicalForum_🔗 https://t.co/eAXXm2GwZX

📍@CCNewSouthWales | @syd_health
#⃣ #LungCancer | #LungCancerTesting | #PublicHealth | #LungCancerCare

[Dr Sarah Heynemann @CancerEthicsDoc]

@ausyoungoncs @SamuelXStevens @sharonnahm @ktambui @LindaMileshkin

[Dr Sarah Heynemann @CancerEthicsDoc]

Looking fwd to inaugural @MOGA_ORG ethics webinar Wed 19/3- on COIs in oncology, with stellar line-up including: Prof @WendyLipworth Dr Lisa Parker Prof @jrzalcberg & Prof Michael Millward.

COIs what are they? when could they be a problem? how might we manage them?

Link below:

[Dr Sarah Heynemann @CancerEthicsDoc]

https://t.co/7LMIYfqY4b

[Katie Gillies @GilliesKatie]

Do you work on clinical trials?

We need your help to understand the challenges to designing & delivering greener trials. Only 30 responses so far but we can all have a say on this topic. Please take 10 minutes to tell us what you think https://t.co/ZNjLubYo6j

RTs welcome

[Dr Sarah Heynemann @CancerEthicsDoc]

@AzadOncology @UniMelb @melkauf2018 @PeterMacCC @pros_tic @ANZUPtrials @COSAoncology @neerajaiims @EdmondMKwan @PCFnews @DrMHofman @gu_onc @_ShankarSiva Congratulations Arun!

[Sanjay Popat @DrSanjayPopat]

With ADCs bringing cytotoxic payloads, good to get a reminder in these basics, to understand toxicities

[Marion Campbell @MarionKCampbell]

It’s the run up to the holidays so time to resurrect #MethodologyMonday #19. Published c1906 in Nature by the statistician Francis Galton, here is the scientific way to cut your Christmas cake 🎂🎄🔪😊 Enjoy!
https://t.co/w0PiYVp3Kc

[Nicolas Hart @DrNicolasHart]

Our latest in @ActaOncol led by @JuliaLaiKwon on survivorship care for advanced or metastatic cancer.

⏳ Regular discussions about prognosis
✅ Assessment of unmet needs
📝 Referral to services (PROMs)
🆕 New models of care: Surv and Pall
☎️ Communication and care coordination.